Earlier this month, more than 45,000 oncology stakeholders convened at the American Society of Clinical Oncology (ASCO) congress in Chicago to share, learn, and debate the latest cutting-ed
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
